Synergistic inhibition of cyclooxygenase-2 expression by vitamin E and aspirin

Free Radical Biology and Medicine

Volumn 29, Issue 11, 2000, Pages 1135-1142

  Abate, Aida ^a   Yang, Guang ^b   Dennery, Phyllis A ^b   Oberle, Stefanie ^a   Schröder, Henning ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arthritis; Aspirin; Cyclooxygenase 2; Drug synergism; Free radicals; Gene expression; Inflammation; Macrophages; NF B; Prostaglandins; Vitamin E

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ASCORBIC ACID; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROSTAGLANDIN E2;

ARTICLE; CELL LINE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ASCORBIC ACID; ASPIRIN; CELL LINE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DRUG SYNERGISM; GENE EXPRESSION; ISOENZYMES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER; VITAMIN E;

EID: 0034565080     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00425-1     Document Type: Article

References (39)

1. Cyclooxygenases 1 and 2
2. Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis
3. Detection of COX-1 and COX-2 isoforms in synovial fluid cells from inflammatory joint diseases
4. Targets for anti-inflammatory drugs
5. Anti-inflammatory drugs and their mechanism of action
6. A reevaluation of aspirin therapy in rheumatoid arthritis
7. Current medicinal approaches to the treatment of rheumatoid arthritis
8. Gastrointestinal-sparing anti-inflammatory drugs; the development of nitric oxide-releasing NSAIDs
9. Chain breaking antioxidant status in rheumatoid arthritis; clinical and laboratory correlates
10. Serum antioxidants and risk of rheumatoid arthritis
11. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis?
12. Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial
13. Vitamin E in therapy of rheumatic diseases
14. Effectiveness of vitamin E in comparison with diclofenac sodium in treatment of patients with chronic polyarthritis
15. Effect of various combinations of DL-alpha-tocopherol and acetylsalicylic acid on adjuvant arthritis in the rat
16. Animal models of arthritis; relevance to human disease
17. Protease inhibitors protect macrophages from lipopolysaccharide-induced cytotoxicity; possible role for NF-κB
18. A radioimmunoassay for 6-ketoprostaglandin F1alpha
19. Lipopolysaccharide-induced expression of cyclooxygenase-2 in mouse macrophages is inhibited by chloromethylketones and a direct inhibitor of NF-κB translocation
20. Rapid colorometric assay for cellular growth and survival; application to proliferation and cytotoxocity assays
21. Aspirin increases ferritin synthesis in endothelial cells; a novel antioxidant pathway
22. Direct comparison of GAPDH, beta-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia
23. Induction of heme oxygenase-1 gene expression by lipopolysaccharide is mediated by AP-1 activation
24. Relative bioavailability of RRR- and all-rac-alpha-tocopheryl acetate in humans; studies using deuterated compounds
25. Novel urinary metabolite of alpha-tocopherol, 2,5,7,8-tetramethyl-2(2'-carboxyethyl)-6-hydroxychroman, as an indicator of an adequate vitamin E supply
26. Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas
27. Age-associated increase in PGE2 synthesis and COX activity in murine macrophages is reversed by vitamin E
28. Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation; role of arachidonic acid
29. Aspirin inhibits interleukin-1-induced prostaglandin H synthase expression in cultured endothelial cells
30. Redox regulation of NF-κ B activation
31. Transcriptional regulation of fatty acid cyclooxygenases-1 and -2
32. Involvement of NF-κ B in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages
33. Inhibition of NF-κ B by sodium salicylate and aspirin
34. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I kappa B kinase-beta
35. Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells
36. Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks
37. Aspirin protects endothelial cells from oxidative stress-possible synergism with vitamin E
38. Randomized trials of primary prevention of cardiovascular disease in women. An investigator's view
39. Vitamin E and heart disease; basic science to clinical intervention trials